Orion Holdings

001800 · KOSPI · Financials · SMALL CAP

Updated terms.

Orion Holdings updated the disclosed terms of a subsidiary's acquisition of LigaChem Biosciences Co., Ltd., now worth US$55.8M.

M&A([Amended] Decision to acquire shares/equity in another company (voluntary) (subsidiary))· FILED 2026-07-16· RCEPT 20260716801075

US$55.8MDeal value
1.3%vs. company assets

Converted at 1 USD ≈ ₩1,478.85 (filing-date rate, 2026-07-16 close)

What happened

Orion Holdings updated the disclosed terms of a subsidiary's acquisition of LigaChem Biosciences Co., Ltd., now worth US$55.8M.

For context, this deal is worth about 1.3% of the company's consolidated total assets.

TargetLigaChem Biosciences Co., Ltd.
Deal valueUS$55.8M
vs. company assets1.3%
Filed2026-07-16, [Amended] Decision to acquire shares/equity in another company (voluntary) (subsidiary)
SourceDART rcept 20260716801075 → open original filing

Versions of this filing

  1. 2026-06-26Original
  2. 2026-07-16Amendment 1 (this page)

Source: DART. Information only, not investment advice.

For informational purposes only. This is not investment advice, a recommendation, or a solicitation to buy or sell any security. Do your own research; any investment decision is your own responsibility.

Data from DART, Korea's official corporate-filing system. Data sourced from official DART filings. Accuracy is not guaranteed. Figures are as of the date shown. As of 2026-07-16 (KST). · Converted at 1 USD ≈ ₩1,325 (rate of 2026-10-21).

Company summaries are generated and may contain errors; financial figures are mapped directly from official filings.